These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 4808388)

  • 1. [Experience in the study of the immunogenicity of killed influenza vaccine, purified and concentrated by the method of sorption chromatography].
    Malafeeva LK; Daĭter AB; Peradze TV; Fridman EA; Tentser PS
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():67-73. PubMed ID: 4808388
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of inactivated influenza vaccine, purified by adsorption chromatography on porous glas.
    Bresler S; Kolikov V; Katushkina N; Molodkin V; Friedman E; Zheleznova H; Malafeieva L; Peradze T; Beljakov V; Ivanov K
    Med Biol; 1975 Dec; 53(6):456-61. PubMed ID: 1214539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement of the preparation of anti-influenza donor gamma globulin. Report 2. Testing of the immunogenicity of the killed vaccine, purified and concentrated by means of gradient centrifugation].
    Malafeeva LK; Fridman EA; Tentser PS; Geft RA; Sokolov NN
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():78-83. PubMed ID: 4143405
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model.
    Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M
    Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation data from experimental series on a killed influenza vaccine purified and concentrated by differential and density gradient centrifugation. I. Laboratory evaluation data].
    Karpukhin GI; Popov IV; Malikova EV
    Tr Inst Im Pastera; 1976; 47():154-6. PubMed ID: 1052580
    [No Abstract]   [Full Text] [Related]  

  • 6. Simultaneous application of influenza chemovaccine and "Vaxigrip" preparations with BCG.
    Zykov MP; Subbotina TI; Rudenko LG; Kaplin NN
    Acta Virol; 1983 Mar; 27(2):160-7. PubMed ID: 6135335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
    Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
    Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An immunogenicity and reactogenicity study of a purified, inactivated trivalent influenza vaccine for parenteral administration prepared for the 1996-1997 season].
    Lupulescu E; Ioniţă E; Botez D; Matepciuc M; Tabra ME; Tecu C; Alexandrescu V; Munţiu A
    Bacteriol Virusol Parazitol Epidemiol; 1997; 42(1-2):110-2. PubMed ID: 9235136
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.
    Garcia A; Johnson H; Srivastava DK; Jayawardene DA; Wehr DR; Webster RG
    Avian Dis; 1998; 42(2):248-56. PubMed ID: 9645315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with monovalent and bivalent influenza vaccines in Canada 1976.
    Laurence GD; Ashford WR; Pearson EW
    Dev Biol Stand; 1977 Jun 1-3; 39():209-12. PubMed ID: 564310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine response following its simultaneous application with BCG 1st report.
    Zykov MP; Raphaelskaya TI
    Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of the host cell on standardisation of influenza vaccine potency.
    Wood JM; Dunleavy U; Newman RW; Riley AM; Robertson JS; Minor PD
    Dev Biol Stand; 1999; 98():183-8; discussion 197. PubMed ID: 10494972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys.
    Fu TM; Grimm KM; Citron MP; Freed DC; Fan J; Keller PM; Shiver JW; Liang X; Joyce JG
    Vaccine; 2009 Feb; 27(9):1440-7. PubMed ID: 19146898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and safety of a novel liposomal influenza subunit vaccine (INFLUSOME-VAC) in young adults.
    Ben-Yehuda A; Joseph A; Zeira E; Even-Chen S; Louria-Hayon I; Babai I; Zakay-Rones Z; Greenbaum E; Barenholz Y; Kedar E
    J Med Virol; 2003 Apr; 69(4):560-7. PubMed ID: 12601765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single radial immunodiffusion potency test for standardization of indigenous equine influenza vaccine.
    Gupta AK; Yadav MP; Uppal PK
    Indian J Exp Biol; 1993 Dec; 31(12):944-7. PubMed ID: 8112772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement of the preparation of anti-influenza donor gamma-globulin. Report 1. Experience in the cultivation of the killed influenza vaccine, purified and concentrated by means of gradient centrifugation].
    Sokolov NN; Zhukova TIa; Malafeeva LK; Geft RA
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():74-7. PubMed ID: 4143404
    [No Abstract]   [Full Text] [Related]  

  • 20. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.